Michel Aurrand-Lions
8Patents
3h-index
4Co-inventors
42Inventor score
Filing activity: Dec 18, 2003 → Feb 2, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7642341B2 | Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer | Chemistry; Metallurgy | 5 | Expired |
| US7790863B2 | Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer | Physics | 5 | Active |
| US8007797B2 | Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use | Chemistry; Metallurgy | 3 | Active |
| US8093010B2 | Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US7670826B2 | Confluence regulated adhesion molecules useful in modulating vascular permeability | Emerging Cross-Sectional Technologies | 1 | Active |
| US7393651B2 | Confluence regulated adhesion molecules useful in modulating vascular permeability | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8143056B2 | Vascular adhesion molecules and modulation of their function | Emerging Cross-Sectional Technologies | 0 | Active |
| US9107936B2 | Antagonists of GRASP55 for use as a medicament | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.